Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

A Prospective Registry of Participants with a Confirmed Diagnosis of Cancer Who Require Intermediate or High-Risk Regimen Chemotherapy Along With UDENYCA® (Pegfilgrastim-cbqv) Administered as Either Same Day or Next Day Therapy [PROTOCOL # CHS-1701-09] [UDENYCA] NCT number
Principal Investigator(s)
Christopher Del Prete, MD
Coherus BioSciences
Angela Bayer, RN at 203-358-8879


  • Bennett Cancer Center
    One Hospital Plaza
    Stamford, CT 06902
    Main: 203-276-2695

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.